Reviva Pharmaceuticals (RVPH) Earnings (2018 - 2026)
Reviva Pharmaceuticals (RVPH) earnings from May 31, 2018 to Mar 31, 2026. The TTM Reviva Pharmaceuticals (RVPH) earnings is -$17M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Reviva Pharmaceuticals (RVPH) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -42.50% |
| 3 Years TTM | -15.69% |
| 5 Years TTM | +36.65% |
Annual Earnings change of Reviva Pharmaceuticals (RVPH)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$3.20M | -83.89% |
| 2025 | -$20M | -33.62% |
| 2024 | -$30M | -23.79% |
| 2023 | -$39M | +38.92% |
| 2022 | -$28M | +231.69% |
| 2021 | -$8.52M | +125.40% |
| 2020 | -$3.78M | +344.71% |
| 2019 | -$850K | -414.81% |
| 2018 | $270K | N/A |
Comparison Reviva Pharmaceuticals (RVPH) five years earnings CAGR with competitors
Reviva Pharmaceuticals (RVPH) five years earnings CAGR is 46.40%.